Wolfgang Miesbach: Practice-Changing Insights on the Efficacy and Safety of Platelet Transfusions at the EHA-SWG
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Platelet transfusions in inherited platelet disorders – powerful, but never ‘routine’
At the EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, Roger Schutgens gave a practice‑changing talk on the efficacy and safety of platelet transfusions:
Platelet transfusions remain an important possibility.
But every unit carries a price:
- alloimmunization
- refractoriness
- TRALI/TACO– particularly critical for younger patients who may need repeated support.
What is striking:
Different societies suggest different platelet thresholds for the same procedures.
Many ‘strong’ recommendations are built on low or very low evidence.
In inherited platelet disorders, where function outweighs count, a single cutoff number is simply not enough.
‘Just give platelets’ is not a strategy.
We need individualized, phenotype‑driven decisions that balance immediate bleeding risk against the long‑term consequences of transfusion.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden
-
Nov 13, 2026, 15:10Sally Mandour: Ringed Sideroblasts in Peripheral Blood
-
Nov 13, 2026, 14:58Lorena Arranz: The Power of Patient Engagement in Advancing MPN Research
-
Nov 13, 2026, 14:46Shehab Mohamed: SGLT2 Inhibitors in Anemia Management
-
Nov 13, 2026, 14:25Dino Mehic: Targeting TFPI in Unexplained Bleeding Disorders
-
Nov 13, 2026, 14:19Bahar Artım Esen: Rituximab in Antiphospholipid Syndrome
-
Nov 13, 2026, 14:13Tagreed Alkaltham: What If One Blood Donation Could Produce Units Of Blood?
-
Nov 13, 2026, 13:27Shirley D’Sa: Connecting European and Mayo Clinic Experts in MGCS Research and Care
-
Nov 13, 2026, 13:20Josie Sirna: Representing the Thalassemia Community at Canada’s Rare Disease Conference in Halifax